[HTML][HTML] Polygala tenuifolia and Acorus tatarinowii in the treatment of Alzheimer's disease: a systematic review and meta-analysis
Y Zhang, J Tian, J Ni, M Wei, T Li, J Shi - Frontiers in Pharmacology, 2024 - frontiersin.org
Background: The complexity of Chinese medicine treatment for Alzheimer's disease (AD)
utilizing a multi-herb therapy makes the evidence in current studies insufficient. Herb pairs …
utilizing a multi-herb therapy makes the evidence in current studies insufficient. Herb pairs …
[HTML][HTML] Unveiling the Therapeutic Potentials of Mushroom Bioactive Compounds in Alzheimer's Disease
N Li, H Li, Z Liu, G Feng, C Shi, Y Wu - Foods, 2023 - mdpi.com
Alzheimer's disease (AD) stands as a prevailing neurodegenerative condition (NDs),
leading to the gradual deterioration of brain cells and subsequent declines in memory …
leading to the gradual deterioration of brain cells and subsequent declines in memory …
[HTML][HTML] Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue
GA Reid, S Darvesh - Chemico-Biological Interactions, 2024 - Elsevier
Abstract Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are associated with
amyloid-β (Aβ) plaques and exhibit altered biochemical properties in human Alzheimer's …
amyloid-β (Aβ) plaques and exhibit altered biochemical properties in human Alzheimer's …
[HTML][HTML] Lipoproteins and metabolites in diagnosing and predicting Alzheimer's disease using machine learning
F Wang, A Wang, Y Huang, W Gao, Y Xu… - Lipids in Health and …, 2024 - Springer
Background Alzheimer's disease (AD) is a chronic neurodegenerative disorder that poses a
substantial economic burden. The Random forest algorithm is effective in predicting AD; …
substantial economic burden. The Random forest algorithm is effective in predicting AD; …
Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease
C Peña-Bautista, L Álvarez-Sánchez… - International Journal of …, 2024 - mdpi.com
Alzheimer disease (AD) is a heterogeneous and complex disease in which different
pathophysiological mechanisms are involved. This heterogenicity can be reflected in …
pathophysiological mechanisms are involved. This heterogenicity can be reflected in …
[HTML][HTML] Sex-and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer's disease mice
A Papazoglou, C Henseler, S Weickhardt, J Teipelke… - Plos one, 2024 - journals.plos.org
A variety of Alzheimer's disease (AD) mouse models has been established and
characterized within the last decades. To get an integrative view of the sophisticated …
characterized within the last decades. To get an integrative view of the sophisticated …
AdipoRon Ameliorates Synaptic Dysfunction and Inhibits tau Hyperphosphorylation through the AdipoR/AMPK/mTOR Pathway in T2DM Mice
W Zhao, W Zhang, Y Hu, Y Zhou, J Zhao, Y Li… - Neurochemical …, 2024 - Springer
There is growing evidence showing that adiponectin (APN) can improve Alzheimer's
disease (AD)-like pathological changes by improving insulin resistance. However, the role of …
disease (AD)-like pathological changes by improving insulin resistance. However, the role of …
MSC-Derived Extracellular Vesicles Alleviate NLRP3/GSDMD-Mediated Neuroinflammation in Mouse Model of Sporadic Alzheimer's Disease
L Lin, L Huang, S Huang, W Chen, H Huang… - Molecular …, 2024 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disease, with sporadic
form being the predominant type. Neuroinflammation plays a critical role in accelerating …
form being the predominant type. Neuroinflammation plays a critical role in accelerating …
New approach for early and specific Alzheimer disease diagnosis from different plasma biomarkers
A Forte, S Lara, C Peña-Bautista, M Baquero… - Clinica Chimica …, 2024 - Elsevier
Abstract Background Alzheimer Disease (AD) is a complex pathology, in which several
biochemical pathways could be involved. Therefore, the development of clinical studies …
biochemical pathways could be involved. Therefore, the development of clinical studies …
Establishment of a comprehensive diagnostic model for neuromyelitis optica spectrum disorders based on the analysis of laboratory indicators and clinical data
W Jiang, X Yin, Y Wang, Y Ding, Y Pan, G Zheng… - Neurological …, 2023 - Springer
Background To establish a comprehensive diagnostic model for neuromyelitis optica
spectrum disorders (NMOSDs) based on laboratory indicators and clinical data. Methods A …
spectrum disorders (NMOSDs) based on laboratory indicators and clinical data. Methods A …